Patents buttress and backstop growth for medical technology (medtech) companies, period. This is especially so for early-stage ventures staking their claim in the medtech ecosystem. A strategic patent portfolio is an essential building block to have in place for a medtech company’s growth and success, especially when it comes to generating revenue or fundraising. And, for a medtech company at any stage, having a solid patent portfolio can lead to licensing, joint ventures, and collaboration opportunities with strategic partners.

Continue reading the full article, published by MedTech Innovation News Dec. 1, 2023.

Photo of Chinh H. Pham Chinh H. Pham

Chinh H. Pham is Co-Chair of the Venture Capital & Emerging Technology Practice at Greenberg Traurig and is an intellectual property attorney with experience in the strategic creation, implementation and protection of IP rights for technology and life science clients, including those in

…

Chinh H. Pham is Co-Chair of the Venture Capital & Emerging Technology Practice at Greenberg Traurig and is an intellectual property attorney with experience in the strategic creation, implementation and protection of IP rights for technology and life science clients, including those in the areas of software, artificial intelligence, virtual and augmented reality, blockchain, video gaming, nanotechnologies, medical devices, electro-mechanical devices, telecommunications, data mining, and electronic commerce. He can be reached at chinh.pham@gtlaw.com.

Read more about Chinh H. PhamEmailChinh's Linkedin Profile
Show more Show less
Photo of Joshua I. Rudawitz Joshua I. Rudawitz

Joshua I. Rudawitz has more than 15 years of multifaceted strategic intellectual property law experience, including as a Primary Patent Examiner with the U.S. Patent and Trademark Office (USPTO). Josh focuses his practice on the strategic development of IP portfolios in fields including

…

Joshua I. Rudawitz has more than 15 years of multifaceted strategic intellectual property law experience, including as a Primary Patent Examiner with the U.S. Patent and Trademark Office (USPTO). Josh focuses his practice on the strategic development of IP portfolios in fields including medical and mechanical devices; consumer electronics; software and mobile applications; and business and commercial methods. He can be reached at rudawitzj@gtlaw.com.

Read more about Joshua I. RudawitzEmailJoshua's Linkedin Profile
Show more Show less